There are no items.
Events
- BGI hit with $8m damages bill in patent dispute with Illumina
- Moderna exposed after losing COVID-19 vaccine patent decision
- Fed Circuit split decision denies Biogen’s bid to revive MS drug patent
- Omicron variant delays COVID-19 IP waiver debate
- Biofrontera settles patent dispute with Dusa over skin treatment